1315 CAPITAL
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.
1315 CAPITAL
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
2014-01-01
Status:
Active
Contact:
+1 215 662 1315
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Alterna Capital Partners
Alterna invests in Core Capital Assets for the transportation, industrial and energy sectors.
Attain Capital Partners
Attain Capital Partners invests in growth-stage companies in the knowledge economy.
Brain-Too-Free Ventures
Brain-Too-Free Ventures provide inorganic growth capital and shareholder liquidity for rapidly growing, privately-held companies.
Camden Partners
Camden Partners provides growth capital to companies in the education, healthcare and technology-enabled business services sectors.
Country Garden Venture Capital
Country Garden Venture Capital focuses on the four major investment themes of industrial chain, technology, health, and consumption.
Fannin Innovation Studio
Fannin Innovation Studio focuses on commercializing innovation developed in the Texas Medical Center institutions.
Hopewell Ventures
Hopewell Ventures provides equity capital and strategic expertise to high-growth businesses, primarily in the Midwest.
July Ventures
July Ventures provides patient capital and partners with passionate entrepreneurs in building and scaling their businesses.
Nickleby Capital
Nickleby Capital provides investment capital to help accelerate growth in high-potential companies.
RiverGlade Capital
RiverGlade Capital is a growth-oriented private equity firm that invests in healthcare services companies.
Route 66 Ventures
Route 66 Ventures provides venture capital and credit solutions to emerging financial technology and services companies.
Spring Lane Capital
Spring Lane Capital offers a new approach to faster growth for companies that deploy smaller-scale projects and equipment.
Synergy Ventures
Synergy has been actively involved in medical technology and venture capital since 1996.
The Conscious Fund
The Conscious Fund invests in early stage ventures in plant-powered medicine.
Xerox Venture Capital
Xerox Venture Capital Companies whose technology or products are strategically relevant to Xerox.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-30 | Homestead Smart Health Plans | Homestead Smart Health Plans acquired by 1315 Capital | N/A |
| 2021-05-11 | miraDry | miraDry acquired by 1315 Capital | N/A |
| 2019-01-16 | Biocoat | Biocoat acquired by 1315 Capital | N/A |
| 2018-10-17 | Centurion Service Group | Centurion Service Group acquired by 1315 Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-13 | NutriSense | 1315 Capital investment in Series A - NutriSense | 25 M USD |
| 2021-09-01 | Onkos Surgical | 1315 Capital investment in Series C - Onkos Surgical | 22.5 M USD |
| 2019-04-08 | Encore Dermatology | 1315 Capital investment in Debt Financing - Encore Dermatology | 20 M USD |
| 2017-11-09 | Misonix | 1315 Capital investment in Post-IPO Equity - Misonix | 25 M USD |
| 2017-07-21 | Colorescience | 1315 Capital investment in Series C - Colorescience | 15 M USD |
| 2017-04-19 | Onkos Surgical | 1315 Capital investment in Series B - Onkos Surgical | 17.6 M USD |
| 2015-10-31 | JDS Therapeutics LLC | 1315 Capital investment in Private Equity Round - JDS Therapeutics LLC | 16 M USD |
| 2015-10-06 | Onkos Surgical | 1315 Capital investment in Series A - Onkos Surgical | N/A |